CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.7B, above the global median of $1.15B
- FinancialsAltman Z-Score 1.98: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.49%Below 5Y avg (0.70%)
Annual Rate
INR 5.00Paid annual
Payout Ratio
19.9%Sustainable
Last Ex-Dividend
Jul 23, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
161.97BINR1.70B · vs all stocks (USD)
Trailing P/E
40.82xRevenue (TTM)
82.80BINR869.61M · vs all stocks (USD)
Profit Margin
4.81%Beta
0.5090xvs all stocks
52-Week Change
-16.34%vs all stocks
Market Capitalization
161.97BINR1.70B · vs all stocks (USD)
Enterprise Value
185.22BINR1.95B · vs all stocks (USD)
Trailing P/E
40.82xForward P/E
20.13xPEG Ratio
2.20xPrice to Sales (TTM)
1.96xPrice to Book (MRQ)
2.28xEnterprise to Revenue
2.24xEnterprise to EBITDA
14.70xGross Margin
68.61%Profit Margin
4.81%Operating Margin
9.72%Return on Assets (TTM)
3.62%Return on Equity (TTM)
5.96%Revenue (TTM)
82.80BINR869.61M · vs all stocks (USD)
Revenue per Share (TTM)
522.54INRUpdated Jul 20, 2026Quarterly Revenue Growth
18.70%Gross Profit (TTM)
56.35BINR591.88M · vs all stocks (USD)
EBITDA (TTM)
13.32BINR139.86M · vs all stocks (USD)
Net Income (TTM)
3.98BINR41.85M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-22.30%Operating Cash Flow (TTM)
12.27BINR128.85M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-5.68BINR-59.68M · vs all stocks (USD)
Trailing Annual Dividend Rate
5.00INRUpdated Jul 20, 2026Trailing Annual Dividend Yield
0.49%vs all stocks
5-Year Average Dividend Yield
0.70%vs all stocks
Payout Ratio
19.94%Minority Interest (Equity)
28.00MINRFY2026 · Mar 31, 2026Revenue
82.25BINRFY2026 · Mar 31, 2026Cost of Goods Sold
26.44BINRFY2026 · Mar 31, 2026Gross Profit
55.81BINRFY2026 · Mar 31, 2026Operating Income
8.19BINR86.06M · vs all stocks (USD)
Pre-tax Income
6.14BINRFY2026 · Mar 31, 2026Income Tax Expense
2.17BINRFY2026 · Mar 31, 2026Net Income
3.98BINRFY2026 · Mar 31, 2026EBIT
8.26BINRFY2026 · Mar 31, 2026EBITDA (Income Statement)
13.26BINRFY2026 · Mar 31, 2026Other Operating Expenses
16.75BINRFY2026 · Mar 31, 2026Non-operating Interest Expense
2.12BINRFY2026 · Mar 31, 2026Minority Interests (P&L)
10.00MINRFY2026 · Mar 31, 2026Preferred Stock Dividends
0.00INRFY2026 · Mar 31, 2026Operating Cash Flow
8.90BINRFY2026 · Mar 31, 2026Free Cash Flow
-4.57BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents (End of Period)
12.67BINRFY2026 · Mar 31, 2026Starting Profit (CF Statement)
6.14BINRFY2026 · Mar 31, 2026Stock-based Compensation
118.00MINRFY2026 · Mar 31, 2026Other Non-cash Items
2.34BINRFY2026 · Mar 31, 2026Change in Accounts Receivable (CF)
-1.05BINRFY2026 · Mar 31, 2026Change in Other Assets/Liabilities
1.34BINRFY2026 · Mar 31, 2026Capital Expenditures
-13.47BINRFY2026 · Mar 31, 2026Purchase of Investments
-179.00MINRFY2026 · Mar 31, 2026Sale of Investments
14.00MINRFY2026 · Mar 31, 2026Other Investing Activity
791.00MINRFY2026 · Mar 31, 2026Net Investing Cash Flow
-12.84BINRFY2026 · Mar 31, 2026Long-term Debt Issuance
25.71BINRFY2026 · Mar 31, 2026Long-term Debt Payments
-20.13BINRFY2026 · Mar 31, 2026Net Short-term Debt Issuance
-565.00MINRFY2026 · Mar 31, 2026Common Stock Repurchase
-187.00MINRFY2026 · Mar 31, 2026Common Dividends Paid
-795.00MINRFY2026 · Mar 31, 2026Other Financing Charges
-3.00MINRFY2026 · Mar 31, 2026Net Financing Cash Flow
4.04BINRFY2026 · Mar 31, 2026Shares Outstanding
158.39MSharesUpdated Jul 20, 2026Float Shares
64.17MSharesUpdated Jul 20, 2026% Held by Insiders
57.95%vs all stocks
% Held by Institutions
21.61%vs all stocks
Total Cash (MRQ)
12.68BINR133.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
80.15INRUpdated Jul 20, 2026Total Debt (MRQ)
36.15BINR379.65M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.5094xCurrent Ratio (MRQ)
1.62xBook Value per Share (MRQ)
448.50INRUpdated Jul 20, 2026Total Assets
155.23BINR1.63B · vs all stocks (USD)
Total Current Assets
41.09BINRFY2026 · Mar 31, 2026Total Liabilities
84.27BINRFY2026 · Mar 31, 2026Total Non-current Assets
114.13BINRFY2026 · Mar 31, 2026Total Non-current Liabilities
58.88BINRFY2026 · Mar 31, 2026Total Current Liabilities
25.39BINRFY2026 · Mar 31, 2026Cash & Cash Equivalents
12.67BINRFY2026 · Mar 31, 2026Other Short-term Investments
2.19BINRFY2026 · Mar 31, 2026Accounts Receivable
10.70BINRFY2026 · Mar 31, 2026Inventory
12.31BINRFY2026 · Mar 31, 2026Accounts Payable
12.34BINRFY2026 · Mar 31, 2026Short-term Debt
3.15BINRFY2026 · Mar 31, 2026Other Current Liabilities
3.40BINRFY2026 · Mar 31, 2026Long-term Debt
33.00BINRFY2026 · Mar 31, 2026Other Non-current Liabilities
13.72BINRFY2026 · Mar 31, 2026Common Stock (Book)
158.00MINRFY2026 · Mar 31, 2026Total Shareholders' Equity
70.96BINR745.25M · vs all stocks (USD)
52-Week Low
786.05INRUpdated Jul 20, 202652-Week High
1.25KINRUpdated Jul 20, 202652-Week Change
-16.34%vs all stocks
Beta
0.5090xvs all stocks
50-Day MA
983.29INRUpdated Jul 20, 2026200-Day MA
990.51INRUpdated Jul 20, 2026Avg 10-Day Volume
177.47KSharesUpdated Jul 20, 2026Avg 30-Day Volume
117.83KSharesUpdated Jul 20, 2026Diluted EPS (TTM)
25.05INRUpdated Jul 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.69Profit Margin: 0.05
Financial Health
Altman Z-Score 1.98: grey zoneSignificant
Altman Z-Score: 1.98
High earnings qualityNotable
Earnings Quality Score: 0.57
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.7B, above the global median of $1.15BNotable
Market cap (USD): 1,701,136,405.849Global Median: 1,146,734,693.424
Revenue is $869.61M, above the global median of $520.53MNotable
Revenue (USD): 869,606,422.954Global Median: 520,528,949.311
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhejiang Conba Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Cofoe Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shanghai MicroPort Endovascular MedTech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Taysha Gene Therapies Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Alembic Pharmaceuticals Ltd.
Tier 1ProductionApproval-Gated PipelineRule
4DMedical Limited
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
MapLight Therapeutics, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Pharmablock Sciences Nanjing Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Inventisbio Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Tibet Cheezheng Tibetan Medicine Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule